FDA Approves Ready-to-Use Phenylephrine Injection |
Clinical News
eMediNexus Coverage from: 
FDA Approves Ready-to-Use Phenylephrine Injection

1 Read Comments                

The US Food and Drug Administration (FDA) has approved the first ready-to-use formulation of phenylephrine HCl injection (Biorphen, Eton Pharmaceuticals) for treatment of clinically important hypotension resulting primarily from anesthesia-associated vasodilation, the company has announced.

Previously, phenylephrine injection was only available in a highly concentrated formulation requiring manual dilution before use or in ready-to-use formulations obtained from compounding pharmacies… (Medscape)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now